Viewing Study NCT06526234



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06526234
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-23

Brief Title: Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection
Sponsor: None
Organization: None

Study Overview

Official Title: Performance of Non-injected MR Enterography Compared to a Conventional MR Enterography Protocol With Contrast Agent Injection
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Fast-MR
Brief Summary: Entero-MRI is indicated in Crohns disease as part of the initial work-up or follow-up to assess response to treatment complications The protocol for carrying out the examination complies with precise specifications set out in international recommendations To perform the test the small intestine must be distended with a hyperosmolar product This protocol is applied to all patients with no distinction or adaptation

The total duration of the examination is sometimes difficult for patients to bear Ingestion of the product to obtain distension of the small intestine is often poorly tolerated by patients

In a number of cases the entero-MRI may have been normal due to symptomatology regression or other diagnosis The patient therefore underwent a complete examination similar to that of a patient with a pathology requiring characterization

In this context the investigators hypothesize that fast MR sequences are sufficient to discriminate between normal and abnormal examinations
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None